THBD and alkaline phosphatase measurement: Previous studies have shown that the inhibition and/or modification of coagulation by the administration of unfractionated heparin [38,39,40,44], low-molecular-weight heparin (LMWH), or recombinant human soluble thrombomodulin [48] inhibits the development and reduced the severity of AP.